Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Other Peptide Therapies We Offer Sermorelin Supports natural growth hormone production and healthy aging
Dosage and suitability are determined individually by a qualified provider after evaluation
At New Results Medical Weight Loss, BPC-157 is used as part of a personalized peptide protocol to help patients recover faster, improve joint and gut health, and support overall physical resilience, especially during active weight loss programs
BPC 157 is a penta decapeptide composed of 15 amino acids
Chronic and post-surgical cases often run 8 to 12 weeks or longer